Showing results (141-150 of 224) with videos related to
Sort By:
Pageof 23
Breast Cancer Research and Treatment|February 22, 2012
Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancerSebastian F Schoppmann, Anna Berghoff, Carina Dinhof, et al.Histopathology|October 15, 2014
Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastasesAnna Sophie Berghoff, Gerda Ricken, Georg Widhalm, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 casesAna-Iris Schmatz, Berthold Streubel, Elisabeth Kretschmer-Chott, et al.The Journal of Investigative Dermatology|August 16, 2005
Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplatation modelElisabeth Heere-Ress, Johannes Boehm, Christiane Thallinger, et al.International Journal of Oncology|June 6, 2007
Molecular characterization of the desmoplastic tumor stroma in medullary thyroid carcinomaOskar Koperek, Christian Scheuba, Christina Puri, et al.Clinical Neuropathology|August 25, 2020
Analysis of the inflammatory tumor microenvironment in meningeal neoplasmsAnna Sophie Berghoff, Philip Kresl, Orsolya Rajky, et al.Journal of Neuro-Oncology|March 16, 2004
Stabilization of a progressive hemangioblastoma under treatment with thalidomideMaria Piribauer, Thomas Czech, Karin Dieckmann, et al.Breast Cancer Research and Treatment|March 24, 2006
Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancerSebastian F Schoppmann, Alexandra Fenzl, Monika Schindl, et al.The American Journal of Surgical Pathology|May 18, 2012
Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinomaOskar Koperek, Christoph Kornauth, David Capper, et al.Leukemia Research|January 17, 2002
Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1Detlef Haase, Claudia Binder, Jürgen Bünger, et al.Pageof 23